Grab D, Wolf A, Künzel H, Sterzik K
Universitäts-Frauenklinik Ulm.
Zentralbl Gynakol. 1992;114(6):289-91.
In a retrospective cohort study of 252 patients with ectopic pregnancies the possible association between use of clomiphene citrate and the occurrence of an ectopic pregnancy was examined. Seventeen out of 252 patients had been treated with clomiphene. Epidemiologic data and animal experiments suggest, that there may be a role of clomiphene in the etiology of ectopic pregnancy. Marchbanks et al. [6] reported that patients who used clomiphene were found to have a relative risk of 10.0 for ectopic pregnancy. The analysis of our own data show an accumulation of classic risk factors as history of pelvic inflammatory disease or of microsurgery for treatment of tubal disease in the clomiphene group. The higher rate of ectopic pregnancies in patients who have been treated with clomiphene is more likely associated with the diagnosis of infertility than with the use of ovulatory-inducing agents. Clomiphene treatment is no independent risk factor in the etiology of ectopic pregnancy.
在一项针对252例异位妊娠患者的回顾性队列研究中,研究了使用枸橼酸氯米芬与异位妊娠发生之间的可能关联。252例患者中有17例接受过氯米芬治疗。流行病学数据和动物实验表明,氯米芬可能在异位妊娠的病因中起作用。Marchbanks等人[6]报告称,使用氯米芬的患者发生异位妊娠的相对风险为10.0。对我们自己数据的分析显示,氯米芬组中存在盆腔炎病史或输卵管疾病显微手术史等经典危险因素的聚集。接受氯米芬治疗的患者异位妊娠发生率较高,更可能与不孕症诊断有关,而非与促排卵药物的使用有关。氯米芬治疗不是异位妊娠病因中的独立危险因素。